Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05383274 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Study acronym: STREAM
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from Urotronic Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 30, 2026 to Jun 30, 2027 Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Dec 30, 2026 to Dec 30, 2027
    • Eligibility criteria expanded, about 15 words
    • Site details revised at 9 of 9 sites
  2. Notable Primary completion date: Dec 30, 2025 to Jun 30, 2026v6
  3. Minor Site details revised at 5 of 9 sitesv5
  4. Minor Primary completion date: Sep 30, 2025 to Dec 30, 2025
    • Study completion date: Mar 30, 2026 to Dec 30, 2026
    • Site details revised at 1 of 9 sites
    v4
  5. Notable Primary completion date: Nov 30, 2023 to Sep 30, 2025
    • Study sites: 5 to 9
    • Study completion date: Aug 30, 2024 to Mar 30, 2026
    • Collaborators expanded, about 4 words
    v3
  6. Minor Eligibility criteria revised
    • Study description revised
    • Site details revised at 4 of 5 sites
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
6 trials monitored
See 1 trial at risk
Single-arm, prospective study assessing semen quality after treatment with the Optilume Urethral DCB in men between 22 and 65 years of age.
Trial Details
NCT Number NCT05383274
Lead Sponsor Urotronic Inc.
Collaborators: Laborie Medical Technologies Inc.
Conditions
(from sponsor)
Urethral Stricture
Related terms Urethral Stricture
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov